More than 50,000 people have signed up in just two days nationwide for a new phase of vital research set to begin in Chicago. And it seems there are encouraging results coming from the first COVID-19 vaccine tested in the U.S. Chicago is set to be part of a 30,000-person nationwide study led locally by the University of Illinois at Chicago.